ALETEKITUG
UNII YJ4XZ74SWG

Substance Identification & Data

This profile provides standardized clinical and technical data for Aletekitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YJ4XZ74SWG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923284-67-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YJ4XZ74SWG

CAS Registry Number

2923284-67-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALETEKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211830

National Cancer Institute reference terminology for clinical and research data.

INN ID

13155

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-206

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Aletekitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALETEKITUG

Common Names & Synonyms

ALETEKITUG [INN]

ALETEKITUG [USAN]

GSK 1070806 [WHO-DD]

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-456) (VH (HOMO SAPIENS IGHV1-24*01 (82.7%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT (8.8.19) (26-33.51-58.97-115)) (1-126) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (223) (127-224), HINGE 1-15 (225-239), CH2 (240-349), CH3 D12 (365), L14 (367) (350-454), CHS (455-456)) (127-456)), (229-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (VKAPPA (HOMO SAPIENS IGKV1-12*01 (83.2%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (235-235'':238-238'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 18) (HUMAN-RATTUS NORVEGICUS MONOCLONAL GSK1070806 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL GSK1070806 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL18 (INTERLEUKIN 18, IL-18, INTERFERON GAMMA-INDUCING FACTOR, IGIF, INTERLEUKIN-1 GAMMA, IL-1G, IL1F4)), HUMANIZED MONOCLONAL ANTIBODY

Technical Codes

GSK1070806

GSK-1070806

External Clinical & Regulatory Resources

Previous UNIIYJ4RCR5WCS

Next UNIIYJ53T77095